Document ID: chunk:federal_register_of_legislation:F2024N01149:schedule:2:p1
Version: federal_register_of_legislation:F2024N01149
Segment Type: schedule
Provision Reference: sch 2 (pt 1/2)
Character Range: 25613–29621

Schedule 2 – System Functionality

Electronic Medication Chart System Functionality - PBS/RPBS Electronic Medication Chart prescriptions for persons receiving treatment in or at a residential care service at which the person is receiving residential care.

      1.       Residential care service patients

             1.              The system functionality for a patient who is receiving residential care in a residential care service must:
                     1.                  alert for consumers with similar-sounding names; and
                     2.                  ensure that the resident's details include all details listed in paragraph 1.1 of Schedule 1 of this instrument, and are visible on all system screens from which medicines are prescribed, reviewed, supplied or administered.

      2.       Allergies and Drug Reactions (ADRs)

            2.1               The system functionality allergies and adverse reactions for a patient who is receiving residential care in a residential care service must:
                (a)                 allow the user to record administration-related ADRs; and
                (b)                 ensure that allergies and ADRs are visible on all system screens from which medicines are prescribed, reviewed, supplied or administered.

      3.      Period of validity

            3.1               The system functionality for the six month period of validity of the electronic medication chart must:
                (a)                 alert all users when chart is nearing expiry - at least three weeks before expiry; and
                (b)                 not allow for further prescribing, supply or administration of pharmaceutical benefits past the expiry date.

      4.      PBS prescriber

            4.1               The system functionality for a PBS prescriber must:
                (a)                 validate the PBS Prescribers Healthcare Provider Identifier - Individual (HPI-I); and
                (b)                 validate the PBS Prescribers Healthcare Provider Identifier - Organisation (HPI-O).

      5.      Regularly administered and short-term pharmaceutical benefits

            5.1               The system functionality for a regularly administered and short-term pharmaceutical benefit must ensure:
                (a)                 that systems do not default to add Brand; and
                (b)                 for short-term medicines, that the system must only enable administration for the duration specified by the prescriber.

      6.      Insulin pharmaceutical benefits (non-PRN and PRN)

            6.1               The system functionality for pharmaceutical benefit that is insulin must not default to add Brand.

      7.      PRN (as required) pharmaceutical benefits

            7.1               The system functionality for PRN pharmaceutical benefits must ensure that systems must not default to add Brand.

      8.      Variable dose pharmaceutical benefits (non-insulin)

            8.1               The system functionality for a pharmaceutical benefit, other than insulin, that is required to be administered at a variable dose must:
                (a)                 enable prescribing based on:
                    (i)                  age; and
                    (ii)                weight; and
                    (iii)              body surface area; and
                (b)                 automatically calculate the dates that dose changes will apply; and
                (c)                 record and capture pathology results necessary for variable dosing; and
                (d)                 support variable dosing regimens including tapering regimens and dose rounding; and
                (e)                 provide support tools and templates to assist variable dose prescribing and calculations; and
                (f)                  must not default to add Brand.

      9.      Schedule 8 (controlled) pharmaceutical benefits

            9.1